Loss-of-function LRP5/6 mutations were identified in osteoporosis pseudoglioma (OPPG) patients, a disease characterized by thinning of the bones and impaired vision (8). This evidence concerns the gene LRP5 and osteoporosis-pseudoglioma syndrome.